CBT performs all necessary toxicity and efficacy studies to register new drugs for IND and NDA and submit the package of documents to FDA.

CBT is a contract research organization (CRO) who tests toxicity and efficacy of new drugs and medical devices and performs all necessary services to submit new drug application to FDA. Analytical and bioanalytical services for drug development, many models to test diseases (including cancer, diabetes, infection, radiation, etc.) and efficacy of new drugs.